Your shopping cart is currently empty

ASI-222 is an aminoglycoside cardiotonic compound. It functions by inhibiting sodium-potassium ATPase (Na+/K+ ATPase) and exhibits positive inotropic effects. ASI-222 can be utilized in cardiovascular disease research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | ASI-222 is an aminoglycoside cardiotonic compound. It functions by inhibiting sodium-potassium ATPase (Na+/K+ ATPase) and exhibits positive inotropic effects. ASI-222 can be utilized in cardiovascular disease research. |
| In vivo | When administered intravenously at a dose of 40 μg/kg, ASI-222 enhances myocardial contractility and increases the maximal rate of left ventricular pressure rise in dogs with intact vagal nerves. |
| Molecular Weight | 519.68 |
| Formula | C29H45NO7 |
| Cas No. | 59006-00-7 |
| Smiles | O[C@@]12[C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](N)[C@@H](C)O5)CC4)[H])(CC[C@]1(C)[C@H](CC2)C=6COC(=O)C6)[H])[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.